| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
Denis Angioletti
BRD | Director/Board Member | 58 | 01/01/2020 |
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +0.07% | -1.38% | +43.65% | +141.27% | 983B | |
| +1.88% | +0.45% | +56.11% | +42.75% | 557B | |
| +1.05% | +4.49% | +26.50% | +71.02% | 406B | |
| +1.17% | -1.93% | +23.33% | +16.35% | 314B | |
| +2.95% | +2.76% | +31.00% | +19.51% | 273B | |
| +2.19% | +2.71% | +29.30% | +35.56% | 272B | |
| +2.47% | +10.13% | -31.50% | -43.27% | 203B | |
| +0.71% | +0.07% | +27.77% | +53.27% | 186B | |
| +0.87% | -1.25% | +18.32% | +62.18% | 155B | |
| Average | +1.35% | -0.92% | +24.94% | +44.29% | 372.26B | |
| Weighted average by Cap. | +1.24% | -2.22% | +32.92% | +66.38% |
Employees
4
Sector
Pharmaceuticals
